Resolved

BIVALIRUDIN INJECTION

AVIR PHARMA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BIVALIRUDIN INJECTION in Canada?

Not currently. The most recent shortage report for BIVALIRUDIN INJECTION 5MG is marked resolved (last updated September 16, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength5MG

Last updated2026-09-16

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02505517

Strength

5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

BIVALIRUDIN

Tier

Unrated

Last Updated

2026-09-16

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from AVIR PHARMA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN INJECTION

10MG · DIN 02483343

BACLOFEN INTRATHECAL

0.05MG · DIN 02485494

0.5MG · DIN 02485508

2MG · DIN 02485516

40MG · DIN 02553279

100MG · DIN 02483971